MedTrace Logo

Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

NCT01395849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2116

Last updated 2017-05-16

No results posted yet for this study

Summary

The purpose of this post-marketing surveillance is to detect adverse drug reactions (particularly clinically significant adverse drug reactions) occurring in clinical settings, to examine factors likely to affect the safety and efficacy in the Japanese asthma patients treated with fluticasone propionate and salmeterol xinafoate.

Conditions

Interventions

DRUG

Salmeterol and Fluticasone

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-09-30
Completion
2011-03-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01395849 on ClinicalTrials.gov